Found 545563 clinical trials
Sort by:
Omalizumab for the Monotherapy Treatment of Patients With Allergy to Foods of Plant Origin Due to Sensitization to LTP and Profilin.
Not yet recruiting
- Conditions
- Food Allergies
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
- Target Recruit Count
- 37
- Registration Number
- NCT07073404
Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis
Not Applicable
Not yet recruiting
- Conditions
- Pulmonary Tuberculoses
- Interventions
- Drug: RESP30TBDrug: HRZE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol combination)
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Thirty Respiratory Limited
- Target Recruit Count
- 24
- Registration Number
- NCT07073638
- Locations
- 🇿🇦
TASK Clinical Research Centre, Cape town, Bellville, South Africa
Feasibility, Acceptability and Fidelity of Integrating a Navigation Intervention Into Tobacco Treatment Program
Not Applicable
Completed
- Conditions
- Cancer
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 93
- Registration Number
- NCT07072312
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Transcatheter Fontan Stenting: Impact on Hepatic Stiffness and Exercise Capacity
Recruiting
- Conditions
- Single-ventricleStenosis
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Children's Hospital Los Angeles
- Target Recruit Count
- 20
- Registration Number
- NCT07073612
- Locations
- 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis
Not Applicable
Completed
- Conditions
- CirrhosisCirrhosis AdvancedAcute Kidney InjuryAscites
- Interventions
- Drug: Lower albumin dosage
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Centro Medico Issemym
- Target Recruit Count
- 72
- Registration Number
- NCT07072572
- Locations
- 🇲🇽
Centro Médico ISSEMyM, Metepec, Mexico
IDEAL Discharge Education Program
Not Applicable
Completed
- Conditions
- Laparoscopic Abdominal Surgeries
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Kocaeli University
- Target Recruit Count
- 62
- Registration Number
- NCT07073872
- Locations
- 🇹🇷
Anadolu Medical Center, Kocaeli, Turkey
Comparison Between Efficacy of Trelagliptin and Sitagliptin in Type II Diabetic Patients
Not Applicable
- Conditions
- Diabetes Mellitus Type 2Glycemic Control for Diabetes Mellitus
- Interventions
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Khyber Medical College, Peshawar
- Target Recruit Count
- 126
- Registration Number
- NCT07073768
- Locations
- 🇵🇰
Khyber Teaching Hospital / Khyber Medical College, Peshawar, Khyber Pakhtunkhwa, Pakistan
Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- BioMarin Pharmaceutical
- Target Recruit Count
- 140
- Registration Number
- NCT07073014
- Locations
- 🇺🇸
Nemours Children's Hospital, Delaware (Alfred I. Dupont Hospital for Children), Wilmington, Delaware, United States
🇺🇸Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Effect of Lidocaine-Dexmedetomidine on Pain, Inflammation, and Oxidative Stress After Bariatric Surgery.
Not Applicable
Not yet recruiting
- Conditions
- Postoperative Adjuvant TreatmentMorbid Obesity Requiring Bariatric SurgeryPostoperative AnalgesiaPostoperative PainPostoperative Pain ManagementPostoperative Inflammatory MarkersPostoperative Inflammatory Response
- Interventions
- Drug: Intravenous Lidocaine infusion + Standard AnesthesiaDrug: Intravenous Dexmedetomidine infusion + Standard AnesthesiaDrug: Lidocaine + Dexmedetomidine Combination (LIDEX) + Standard AnesthesiaDrug: 0.9 % Saline Placebo + Standard Anesthesia
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Instituto Mexicano del Seguro Social
- Target Recruit Count
- 104
- Registration Number
- NCT07073846
- Locations
- 🇲🇽
Unidad Médica de Alta Especialidad Hospital de Especialidades del Centro Médico Nacional Siglo XXI, Mexico City, Mexico
An International Study on Pediatric Patients With Rare Tumors.
Recruiting
- Conditions
- Paraganglioma/ PhaeochromocytomaMelanoma and Other Malignant Neoplasms of SkinGastrointestinal Stromal Tumor (GIST)MesotheliomaAdrenocortical TumorPancreatic TumorsEsthesioneuroblastoma, OlfactoryNasopharyngeal Carcinoma (NPC)NUT CarcinomaThyroid Carcinoma
- First Posted Date
- 2025-07-18
- Last Posted Date
- 2025-07-18
- Lead Sponsor
- Azienda Ospedaliera di Padova
- Target Recruit Count
- 6250
- Registration Number
- NCT07072143
- Locations
- 🇮🇹
Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova], Padova, Italy